Displaying items by tag: eye health

We are currently recruiting participants aged 18-30 with normal or corrected to normal vision and participants aged 18-89 with Macular Degeneration/Stargardt's Disease for a clinical research study that aims to understand how individuals learn to use their peripheral vision following the loss of central vision. This study is being conducted in the Civitan International Research Center and involves a total of 27 in-person visits over the course of 1.5 to 3 months. There are 2 MRI visits (1 at the beginning of the study and one at the end), 5 assessment visits (3 baseline assessments and 2 post assessments), and a total of 20 training sessions (in between the baselines and the post assessments). Compensation for full participation in this study is $350.

This is a great opportunity for all to gain experience participating in a clinical research study. All participation would not only contribute to advancing our understanding of perceptual learning and how the brain processes vision, but also holds the potential to improve outcomes for those with central vision loss.

If you or someone you know may be interested, please consider participating.

For more information or to express interest, please email mcmaxwell@uabmc.edu or text or call 205-410-4041, or visit go.uab.edu/brainstudy to sign up!

Thank you for your time and consideration!
Published in Clinical Trials
Researchers from the UAB School of Optometry are currently recruiting those with dry eyes to participate in a research study looking at how a part of your eye's immune system called the complement system is involved in dry eye disease. If eligible, you will be asked to have your eyes evaluated three times, each visit being 3 to 17 days apart. Visit will last between 30 to 90 minutes. You will receive $150 if you are eligible for the study and complete all study procedures. NOW RECRUITING SUBJECTS WITH SJOGREN'S SYNDROME.

If you are interested in participating in this research and want to know more about the study, kindly follow this link to fill out our recruitment survey.
Published in Clinical Trials
Clinical Study for Patients with Dry Eye Associated with Sjögren’s Disease. If you are an adult with Dry Eye Disease associated with Sjögren’s, you may be eligible to take part in a clinical research study being conducted by Sylentis S.A.U. The purpose is to compare the study eye drop to placebo (eyedrop without medication) in treating the signs and symptoms of Dry Eye associated with Sjögren’s.

You may be eligible to take part in the SYL1001_V Study if:
• You are 18 years or older
• You have a diagnosis of Sjögren’s
• Other entry criteria apply and your eligibility will be determined by
the study staff


If you decide to take part in the study, your participation could last approximately 3.5 months and consist of 5 to 6 visits to the study center. You will be reimbursed for each completed visit.
Published in Clinical Trials

Special contact lenses or eye drops can reduce a patient’s final prescription by half in the School of Optometry’s Myopia Control Clinic. That means thinner lenses and also a much lower risk of serious eye problems, including glaucoma and cataracts.

Published in Advances
UAB Eye Care researchers are looking for healthy, nearsighted children between the ages of 5-12 to participate in a study. The study is being done to see if low-dose eye drops of a drug called atropine can help prevent nearsightedness from getting worse. Participants will be randomized to either 0.01% atropine eye drops or placebo eye drops. Participants will use the study eye drop in each eye nightly for two years. Then, there will be 6-months of no eye drops. Study visits start with an enrollment visit and a randomization visit. Then, participants will see their study doctor every 6 months for about 2.5 years. Each visit will be about 1 to 1.5 hours. Study visits are no-cost, and participants are compensated for their time. Glasses may also be provided by the study. If you are interested in learning more about this study, please call Jenifer Montejo at 205-996-0203 or send an email to Dr. Kathy Weise at kweise@uab.edu.
Published in Clinical Trials